SEC 13F Intelligence

Northside Capital Management, LLC / LLY

Northside Capital Management, LLC’s Eli Lilly & Co Position

Does Northside Capital Management, LLC own Eli Lilly & Co (LLY)? Yes — 20.3K shares worth $19M (+1.64% of its 13F portfolio) as of Q1 2026.

Position Value
$19M
Q1 2026
Shares
20.3K
% of Portfolio
+1.64%
Quarters Held
30
currently held

Position History LLY

Reported value by quarter
Q4 ’18: $2MQ4 ’18Q1 ’19: $2MQ2 ’19: $2MQ3 ’19: $2MQ4 ’19: $2MQ4 ’19Q1 ’20: $2MQ2 ’20: $3MQ3 ’20: $3MQ4 ’20: $3MQ4 ’20Q1 ’21: $3MQ2 ’21: $4MQ3 ’21: $4MQ4 ’21: $5MQ4 ’21Q1 ’22: $5MQ2 ’22: $6MQ3 ’22: $6MQ4 ’22: $6MQ4 ’22Q1 ’23: $6MQ2 ’23: $8MQ3 ’23: $9MQ4 ’23: $10MQ4 ’23Q1 ’24: $14MQ2 ’24: $16MQ3 ’24: $16MQ4 ’24: $14MQ4 ’24Q1 ’25: $15MQ2 ’25: $16MQ3 ’25: $15MQ4 ’25: $22MQ4 ’25Q1 ’26: $19Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202620.3K$19M+1.64%
Q4 202520.3K$22M+1.89%
Q3 202520.3K$15M+1.41%
Q2 202520.1K$16M+1.19%
Q1 202517.7K$15M+2.37%
Q4 202417.6K$14M+3.62%
Q3 202417.6K$16M+2.44%
Q2 202417.6K$16M+2.74%
Q1 202417.6K$14M+2.45%
Q4 202317.6K$10M+3.22%
Q3 202317.6K$9M+2.18%
Q2 202317.6K$8M+2.86%
Q1 202317.6K$6M+1.63%
Q4 202217.6K$6M+1.94%
Q3 202217.5K$6M+1.83%
Q2 202217.5K$6M+1.79%
Q1 202217.5K$5M+1.33%
Q4 202117.5K$5M+1.28%
Q3 202117.5K$4M+1.11%
Q2 202117.5K$4M+1.01%
Q1 202117.5K$3M+0.90%
Q4 202017.4K$3M+0.87%
Q3 202017.4K$3M+0.84%
Q2 202017.4K$3M+0.99%
Q1 202017.4K$2M+1.18%
Q4 201917.9K$2M+0.80%
Q3 201917.9K$2M+0.71%
Q2 201917.4K$2M+0.76%
Q1 201917.4K$2M+0.90%
Q4 201817.4K$2M+0.89%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Northside Capital Management, LLC’s full portfolio or all institutional holders of LLY.